Clinical Trials Arena November 17, 2022
Srivani Venna

Viz.ai’s Cloud-based technology expands the recruitment funnel in size, as well as diversity.

Viz.ai and full-service, vascular, clinical research organisation (CRO) Vastrax have announced a strategic collaboration to expedite enrolment in clinical trials for research on new neurovascular therapies.

Viz RECRUIT software will become the artificial intelligence (AI)-powered clinical trial recruitment platform of Vastrax for its neurovascular trials.The software has been designed to identify eligible patients for the trials by scanning their images in real-time.This will enable round-the-clock identification of potential study subjects automatically, and notifications will be sent to research teams.

The Cloud-based technology of Viz.ai expands the recruitment funnel in size, as well as diversity, and streamlines the trial enrolment workflow.

Viz.ai chief clinical officer Jayme Strauss said:...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Clinical Trials, Cloud, Partnerships, Technology, Trends
Related Articles:
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
How can clinical trial outsourcing and operations be optimised?
Using AI to Create New Parkinson’s Treatments: Q&A with Matthias Alder

Share This Article